Genitourinary tract neoplasms are a diverse group of cancers affecting the urinary and reproductive organs, representing nearly a quarter of all cancer diagnoses in the United States and touching the lives of hundreds of thousands of people each year.
Understanding Genitourinary Tract Neoplasms
Genitourinary tract neoplasms refer to cancers that develop in the organs of the urinary system and the male reproductive system. The term “genitourinary” combines both organ systems because they exist in close physical connection with each other. In women, cancers affecting reproductive organs like the ovaries, uterus, cervix, or vagina fall into a separate category called gynecologic cancers.[1]
These cancers can form anywhere within this interconnected system of organs. The urinary tract includes the kidneys, which filter blood and produce urine, the ureters that carry urine from the kidneys to the bladder, the bladder itself where urine is stored, and the urethra through which urine leaves the body. In men, the reproductive organs include the prostate gland, testicles, and penis. Some parts of this system serve dual purposes—for example, in men, both the urethra and penis have roles in both urination and reproduction.[2]
When cancer strikes these areas of the body, it is typically named for the specific organ or gland where it began. The most common types include prostate cancer, bladder cancer, kidney cancer, and testicular cancer. Less common forms include penile cancer, urethral cancer, and cancers of the adrenal glands, which sit atop the kidneys.[3]
A genitourinary tumor develops when a mutation occurs within the DNA of cells that make up different organs in this system. When cells begin dividing very rapidly and out of control, they form a mass. This tumor can be benign, meaning it doesn’t spread and isn’t cancerous, or malignant, meaning it is cancerous and can invade nearby tissues or spread to other parts of the body.[4]
Epidemiology: How Common Are These Cancers
Genitourinary neoplasms represent a significant portion of cancer cases worldwide. In the United States alone, these cancers account for approximately 23% of all malignancies diagnosed each year. An estimated 438,580 new cases are diagnosed annually in men and women combined, with about 65,980 people—roughly 15% of those diagnosed—dying from their disease.[1]
Bladder cancer is the sixth most common cancer in the United States, following breast, prostate, lung, colon cancers, and melanoma. It is the fourth most common cancer in men and the twelfth most common in women. Of approximately 84,000 new bladder cancer cases each year, about 65,000 occur in men and about 19,000 in women. The reasons for this striking difference between sexes are not well understood by researchers.[1]
Men face a significantly higher risk for most genitourinary cancers compared to women. Men are four times more likely to develop bladder cancer than women. However, when women do develop bladder cancer, they often have more advanced forms of the disease because they may not recognize the symptoms early on. Prostate cancer affects about 1 in 8 men during their lifetime, making it one of the most common cancers in males.[5]
The good news is that mortality rates for several genitourinary cancers have been declining over time. From 1971 to 2019, age-standardized cancer death rates have decreased for prostate cancer by 11.9%, bladder cancer by 1.5%, and kidney cancer by 0.9%. These improvements are due in part to earlier detection through better screening methods and advances in treatment options. Testicular cancer, while less common, has maintained a very high survival rate of over 90%.[1]
Causes and How These Cancers Develop
Genitourinary tumors occur when cells in the organs of the urinary or reproductive system undergo genetic mutations that cause them to multiply uncontrollably. Instead of following the normal life cycle of cells—growing, dividing, and dying in an orderly fashion—these mutated cells continue to divide and form tumors. Over time, if left untreated, these cancer cells can invade nearby tissues and spread to other parts of the body through the bloodstream or lymphatic system.[4]
Different types of genitourinary cancers have different cellular origins. Most bladder cancers start in cells called urothelial cells (also known as transitional cells), which line the inside of the bladder and other parts of the urinary tract. These cells have the special ability to stretch when the bladder fills with urine and contract when it empties. When these cells become abnormal and cancerous, they form what is called urothelial carcinoma or transitional cell carcinoma, which accounts for about 90% of all bladder cancers.[6]
Other, less common types of bladder cancer include squamous cell carcinoma, which develops in thin, flat cells that can form after long-term irritation or inflammation of the bladder, and adenocarcinoma, which starts in gland cells and is very rare. Each type behaves differently and may require different treatment approaches.[6]
The biology of genitourinary tumors varies considerably. Some are highly aggressive and grow quickly, spreading to other organs early in their development. Others are indolent, meaning they grow slowly over many years and may never cause serious health problems. This variation means that treatment approaches must be carefully tailored to each patient and each specific type of cancer.[1]
Risk Factors: Who Is Most at Risk
Several factors can increase a person’s likelihood of developing genitourinary cancers, though having risk factors doesn’t mean someone will definitely get cancer, and some people without any known risk factors still develop these diseases.
Smoking is one of the most significant risk factors for bladder and kidney cancers. The bladder works to filter harmful chemicals from cigarette smoke out of the body, and in the process, the bladder lining becomes damaged by repeated exposure to these toxins. Smokers are three times more likely to develop bladder cancer than non-smokers.[4]
Age is another important factor. Genitourinary cancers become more common as people get older. Bladder cancer typically affects people age 55 and older, and about 60% of prostate cancer cases are diagnosed in men who are 65 or older. The risk increases with each passing decade of life.[5]
Exposure to certain chemicals in the workplace can raise cancer risk. People who work with paints, dyes, metals, or petroleum products face higher risks for bladder cancer. Those who work in industries involving rubber, leather, textile, and paint products may be exposed to cancer-causing substances over many years.[5]
Family history plays a role in some genitourinary cancers. Having a father or brother diagnosed with prostate cancer, especially before age 65, increases risk. Some genetic conditions, such as Von Hippel-Lindau disease, increase the risk of kidney cancer. Certain gene changes linked to bladder cancer can also run in families.[5]
Other medical factors can contribute to risk. People with high blood pressure or those who are overweight have higher rates of kidney cancer. Chronic bladder infections, long-term use of urinary catheters, or bladder inflammation can increase bladder cancer risk. Previous cancer treatments, particularly radiation therapy to the pelvis or treatment with certain chemotherapy drugs, can also raise the risk of developing bladder cancer later in life.[5]
Race and ethnicity influence risk for some genitourinary cancers. Prostate cancer is more likely to develop in non-Hispanic Black men, and when it does occur in this population, it tends to be more aggressive. White men are two times more likely to develop bladder cancer than Black men, though the reasons for these differences are not fully understood and likely involve a complex mix of genetic, environmental, and social factors.[5]
Symptoms: Recognizing the Warning Signs
The symptoms of genitourinary cancers vary depending on which organ is affected, but some warning signs should prompt a visit to a healthcare provider. Many of these symptoms can also be caused by conditions that are not cancer, which is why proper medical evaluation is essential.
Blood in the urine, medically called hematuria, is one of the most common symptoms of bladder and kidney cancers. The blood may be visible, turning urine pink, red, or cola-colored, or it may be detected only through laboratory testing. This symptom may come and go, appearing on some days and not others, but it should always be evaluated by a doctor, even if it seems to resolve on its own.[4]
Changes in urination patterns can signal genitourinary problems. These changes might include needing to urinate more frequently than usual, feeling a sudden urgent need to urinate, experiencing pain or burning during urination, or having difficulty starting or maintaining urine flow. Some people notice that their urine stream has become weaker or that they need to wake up multiple times during the night to urinate.[4]
Pain in various locations can indicate genitourinary cancer. Lower back pain, particularly on one side, can be associated with kidney cancer. Pain in the abdomen or pelvis may accompany several types of genitourinary tumors. In men, symptoms related to the prostate or testicles may include a painless lump or swelling in the testicle, discomfort in the testicular area, or a heavy feeling in the scrotum.[5]
Systemic symptoms—those affecting the whole body—can also occur with genitourinary cancers, especially as they advance. These may include unexplained weight loss, loss of appetite, persistent fatigue that doesn’t improve with rest, fever without an obvious cause, and anemia (a condition where the body doesn’t have enough healthy red blood cells to carry adequate oxygen to tissues). Anemia can cause additional symptoms like weakness, pale skin, and shortness of breath.[5]
It’s important to note that many genitourinary cancers, particularly kidney cancer and early-stage prostate cancer, may produce no symptoms at all in their early stages. They may be discovered incidentally during medical examinations or tests performed for other reasons. This is one reason why screening and regular check-ups can be so valuable—they may detect cancer before symptoms appear, when treatment is most likely to be successful.[5]
Prevention and Screening Strategies
While not all genitourinary cancers can be prevented, several strategies can reduce risk or lead to earlier detection when treatment is most effective.
Lifestyle modifications represent the most accessible prevention approach. Quitting smoking is perhaps the single most important step anyone can take to reduce their risk of bladder and kidney cancers. The bladder is particularly vulnerable to the harmful chemicals in tobacco smoke because it stores urine containing filtered toxins from cigarette smoke. Even for people who have smoked for years, quitting reduces risk over time.[4]
Maintaining a healthy weight through balanced nutrition and regular physical activity helps reduce the risk of kidney cancer and may have protective effects against other genitourinary cancers. While no specific diet has been proven to prevent bladder cancer, eating a variety of vegetables and fruits and staying well-hydrated by drinking plenty of water may offer some protection.[4]
Workplace safety matters significantly for those in industries with chemical exposures. Following safety protocols, wearing appropriate protective equipment, and minimizing exposure to paints, dyes, metals, and petroleum products can reduce occupational cancer risk. Employers have responsibilities to provide safe working conditions, and workers should be aware of the materials they handle and any associated health risks.[5]
Regular screening is one of the most effective tools for catching cancer early. For prostate cancer, experts recommend that men discuss screening with their doctor. This conversation should typically begin at age 50 for men at average risk, at age 45 for men at high risk (including African American men and those with a father or brother diagnosed with prostate cancer before age 65), and at age 40 for men at even higher risk (those with multiple close relatives diagnosed with prostate cancer at young ages).[7]
Currently, there are no standard screening tests recommended for bladder or kidney cancer in people without symptoms or specific risk factors. However, people at higher risk—such as those with a history of bladder cancer, chronic bladder infections, or significant chemical exposures—may benefit from discussing personalized screening strategies with their healthcare provider.[5]
For individuals with a strong family history of genitourinary cancers, genetic counseling and testing may be appropriate. Genetic counselors can help determine whether someone carries gene mutations that increase cancer risk and provide information about more intensive screening or prevention strategies for those at elevated genetic risk.[7]
Pathophysiology: How Cancer Changes the Body
Understanding how genitourinary cancers affect normal body function helps explain many of the symptoms patients experience and why treatment approaches differ for various types and stages of cancer.
In a healthy bladder, the wall consists of several layers of specialized tissue. The innermost layer, which comes into contact with urine, is made up of urothelial cells. These cells form a waterproof barrier and have the remarkable ability to stretch and flatten as the bladder fills with urine, then return to their original shape when the bladder empties. A typical bladder can hold about 2 cups of urine before sending signals that it’s time to urinate.[6]
When bladder cancer develops, abnormal cells begin to multiply in the urothelial layer. In the earliest stages, cancer may remain confined to this inner lining, a situation doctors call non-muscle-invasive bladder cancer. These surface tumors can often be removed during a procedure where doctors look inside the bladder with a special instrument. However, even after successful removal, bladder cancer has a strong tendency to come back—about 75% of early-stage bladder cancers recur.[6]
As cancer progresses, it can penetrate deeper into the bladder wall, potentially reaching the muscularis propria, the thick layer of muscle that contracts to push urine out during urination. When cancer reaches this muscle layer, it’s called muscle-invasive bladder cancer, and it has a much higher risk of spreading to other parts of the body. Cancer cells can break away from the primary tumor and travel through lymph vessels or blood vessels to distant organs, a process called metastasis. Common sites of spread include lymph nodes near the bladder, bones, lungs, and liver.[6]
Bladder cancer is typically classified by grade, which describes how abnormal the cancer cells look under a microscope. Low-grade cancers have cells that still resemble normal cells and tend to grow slowly. High-grade cancers have cells that look very abnormal and grow much more aggressively. High-grade cancers are much more likely to invade deeper tissues and spread to other parts of the body. Almost all deaths from bladder cancer result from high-grade disease.[8]
Kidney cancer typically develops when cancer cells form in the lining of the small tubes within the kidney that filter blood and remove waste products. The kidneys play crucial roles beyond making urine—they help regulate blood pressure, control the production of red blood cells, and maintain the body’s chemical balance. When cancer affects kidney tissue, these functions can be disrupted, particularly if a large portion of kidney tissue is damaged or if a kidney must be removed. Fortunately, most people can live normally with just one functioning kidney or even part of one kidney.[5]
In prostate cancer, malignant cells develop in the prostate gland, a walnut-sized structure that surrounds the urethra just below the bladder in men. The prostate produces fluid that nourishes and protects sperm. Because of its location around the urethra, an enlarged or cancerous prostate can cause urinary symptoms by physically squeezing the tube through which urine flows. Prostate cancer often grows very slowly, and many men with prostate cancer die of other causes rather than from the cancer itself. However, some prostate cancers are aggressive and can spread quickly to bones and other organs.[5]
Understanding the biological behavior of different genitourinary cancers has led to a fundamental principle in modern cancer care: treat aggressively those patients who need intensive treatment to save their lives, while avoiding unnecessary treatment for those with slow-growing cancers that may never cause problems. This approach, sometimes called personalized or precision medicine, helps maximize survival while minimizing the side effects and complications of treatment.[1]
